Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)

Documenti analoghi

• Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
  di: Cecilia T Costiniuk, et al.
  Pubblicazione: (2022-01-01)
• Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity
  di: Stephane Isnard, et al.
  Pubblicazione: (2025-01-01)
• Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity
  di: Simeng Bu, et al.
  Pubblicazione: (2024-04-01)
• Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
  di: Cecilia T. Costiniuk, et al.
  Pubblicazione: (2024-04-01)
• Metformin effect on gut microbiota: insights for HIV-related inflammation
  di: Jing Ouyang, et al.
  Pubblicazione: (2020-03-01)